FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JB Acri

Research Profile

Activities & Behaviors

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
JB Acri; AC Thompson; Toni S Shippenberg
Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Dennis K Miller; Peter A Crooks; L Teng; Jeffrey M Witkin; Patrik Munzar; Steven R Goldberg; JB Acri; Linda P Dwoskin
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
Sari Izenwasser; JB Acri; Paul M Kunko; Toni S Shippenberg
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JB Acri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: JB Acri; AC Thompson; Toni S Shippenberg
Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Synapse (New York, N.Y.) 2001;39(4):343-50.
2001: Dennis K Miller; Peter A Crooks; L Teng; Jeffrey M Witkin; Patrik Munzar; Steven R Goldberg; JB Acri; Linda P Dwoskin
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
The Journal of pharmacology and experimental therapeutics 2001;296(3):1023-34.
1998: Sari Izenwasser; JB Acri; Paul M Kunko; Toni S Shippenberg
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Synapse (New York, N.Y.) 1998;30(3):275-83.
1998: Jeffrey M Witkin; Maciej Gasior; JB Acri; M Beekman; Andrew Thurkauf; Jun Yuan; P DeBoer; Håkan V Wikström; Durk Dijkstra
Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
European journal of pharmacology 1998;347(2-3):R1-3.
1997: Beth Geter-Douglass; Jonathan L Katz; KL Alling; JB Acri; Jeffrey M Witkin
Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
The Journal of pharmacology and experimental therapeutics 1997;283(1):7-15.
1997: JB Acri; G Wong; T Lyon; Jeffrey M Witkin; Anthony Basile
Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptors.
Neuroscience 1997;77(2):371-8.
1997: Jeffrey M Witkin; JB Acri; S Gleeson; J E Barrett
Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
Pharmacology, biochemistry, and behavior 1997;56(1):1-7.
1996: Jeffrey M Witkin; JB Acri; G Wong; S Gleeson; J E Barrett
Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
The Journal of pharmacology and experimental therapeutics 1996;277(1):87-96.
1996: JB Acri; B K Siedleck; Jeffrey M Witkin
Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
The Journal of pharmacology and experimental therapeutics 1996;277(1):198-206.
1995: JB Acri; S R Carter; K Alling; Beth Geter-Douglass; Durk Dijkstra; H Wikström; Jonathan L Katz; Jeffrey M Witkin
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands.
European journal of pharmacology 1995;281(2):R7-9.
1995: JB Acri; G Wong; Jeffrey M Witkin
Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptors.
European journal of pharmacology 1995;278(3):213-23.